“The INCA Trial: A Multicenter, Randomized, Phase II, Open-Label Clinical Trial to Evaluate the Combination Therapy With Ipilimumab Plus Nivolumab Versus Chemotherapy (Pemetrexate-Cisplatin) in Patients With Advanced Non-Squamous NSCLC Naive to Treatment”. Principles and Practice of Clinical Research 4, no. 1 (July 25, 2018): 6–13. Accessed June 25, 2024. https://journal.ppcr.org/index.php/ppcrjournal/article/view/62.